A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

NCT04019327 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate Adenocarcinoma
Prostate Neoplasm
Prostate Cancer Metastatic
Castration-resistant Prostate Cancer

Interventions

DRUG: Talazoparib
DRUG: Temozolomide

Sponsor

Memorial Sloan Kettering Cancer Center